#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Cardiomyopathy Fallopian tube cancer Bronchopulmonary aspergillosis Gastrointestinal neuroendocrine tumour Skin cancer Dementia Neoplasm Hyperoxaluria Alveolar proteinosis Urea cycle disorder KBG syndrome B-cell lymphoma Primary mediastinal large B-cell lymphoma Rhabdoid tumour Hypereosinophilic syndrome More trials…

    Learn about Rare Diseases

    Progressive multifocal leukoencephalopathy – Life with Disease Nephrotic syndrome – Trials in Disease Pituitary-dependent Cushing’s syndrome – Basic Information KBG syndrome – Basic Information Systemic mastocytosis – Treatment Chondrosarcoma – Treatment Haemophilia A without inhibitors – Treatment Mucopolysaccharidosis – Basic Information Krabbe’s disease – Trials in Disease Mucopolysaccharidosis III – Trials in Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Cedazuridine PETHIDINE HYDROCHLORIDE Cd19-Car_Lenti_Allo Contezolid Tyrosine Betula Verrucosa Pollen Bt8009 Streptococcus Agalactiae Valaciclovir Leniolisib Phosphate Ribonucleic Acid Oditrasertib Cabotegravir Rimegepant Sorafenib Remifentanil Hydrochloride AZD0120 Tumor Necrosis Factor-Alpha For-6219 Norucholic Acid More therapies…

    Learn about Your Condition

    Turner's syndrome Nephrotic syndrome Peyronie's disease Adenosquamous cell lung cancer Alveolar rhabdomyosarcoma Leukaemia Neuromyopathy Anaemia Gastric cancer Eructation Prinzmetal angina Injury Tympanic membrane perforation Pyrexia Normal pressure hydrocephalus More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Brain injury

  • Study on Allopurinol Sodium for Brain Injury Prevention in Newborns with Critical Congenital Heart Disease Undergoing Heart Surgery

    Recruiting

    3 1 1
    Investigated Diseases:
    • Brain injury
    • Heart disease congenital
    Investigated Drugs:
    • Allopurinol Sodium
    The Netherlands

  • Study on the Effects of Sodium Lactate and Electrolyte Solution in Comatose Patients After Cardiac Arrest

    Recruiting

    2 1 1
    Investigated Diseases:
    • Brain injury
    • Post cardiac arrest syndrome
    • Reperfusion injury
    Investigated Drugs:
    • Sodium Lactate
    • Magnesium Chloride Hexahydrate
    • Potassium Chloride
    Belgium

  • Study on Esketamine Hydrochloride and Sodium Chloride for Patients with Severe Acute Brain Injury

    Recruiting

    3 1 1
    Investigated Drugs:
    • Esketamine Hydrochloride
    • Sodium Chloride
    Denmark

  • Study on Apomorphine Hydrochloride and Sodium Chloride for Patients with Severe Brain Injury and Disorders of Consciousness

    Recruiting

    2 1 1
    Investigated Diseases:
    • Brain injury
    Investigated Drugs:
    • Apomorphine Hydrochloride Hemihydrate
    • Sodium Chloride
    Belgium Spain

  • Study of Brain Injury and Concussion Symptoms Using Tau Tracer [18F]RO6958948 in Patients with Traumatic Brain Injury and Hemorrhages

    Recruiting

    2 1 1
    Investigated Diseases:
    • Brain injury
    Investigated Drugs:
    • 2-(6-[18F]Fluoro-Pyridin-3-Yl)-9H-Dipyrido[2,3-B:3′,4′-D]Pyrrole
    Sweden

  • Intranasal remestemcel therapy for newborns with hypoxic‑ischemic brain injury: a phase II placebo‑controlled trial

    Not yet recruiting

    2 1
    Investigated Diseases:
    • Brain injury
    Investigated Drugs:
    • Remestemcel
    The Netherlands
1 2
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!